Brief Report: Validation of a Urine Tenofovir Immunoassay for Adherence Monitoring to PrEP and ART and Establishing the Cutoff for a Point-of-Care Test

by Monica Gandhi, Peter Bacchetti, Matthew A. Spinelli, Hideaki Okochi, Jared M. Baeten, Oraphan Siriprakaisil, Virat Klinbuayaem, Warren C. Rodrigues, Guohong Wang, Michael Vincent, Tim R. Cressey, Paul K. Drain
Published 2019

Plasma pharmacokinetics and urinary excretion of tenofovir following cessation in adults with controlled levels of adherence to tenofovir disoproxil fumarate

by Tim R. Cressey, Oraphan Siriprakaisil, Rachel W. Kubiak, Virat Klinbuayaem, Pra ornsuda Sukrakanchana, Justice Quame-Amaglo, Hideaki Okochi, Yardpiroon Tawon, Ratchada Cressey, Jared M. Baeten, Monica Gandhi, Paul K. Drain
Published 2020

Urine tenofovir concentrations correlate with plasma and relate to tenofovir disoproxil fumarate adherence: A randomized, directly observed pharmacokinetic trial (target study)

by Paul K. Drain, Rachel W. Kubiak, Oraphan Siriprakaisil, Virat Klinbuayaem, Justice Quame-Amaglo, Praornsuda Sukrakanchana, Suriyan Tanasri, Pimpinun Punyati, Wasna Sirirungsi, Ratchada Cressey, Peter Bacchetti, Hideaki Okochi, Jared M. Baeten, Monica Gandhi, Tim R. Cressey
Published 2020

Development and validation of the first point-of-care assay to objectively monitor adherence to HIV treatment and prevention in real-time in routine settings

by Monica Gandhi, Guohong Wang, Roger King, Warren C. Rodrigues, Michael Vincent, David V. Glidden, Tim R. Cressey, Peter Bacchetti, Matthew A. Spinelli, Hideaki Okochi, Oraphan Siriprakaisil, Virat Klinbuayaem, Nelly R. Mugo, Kenneth Ngure, Paul K. Drain, Jared M. Baeten
Published 2020